Ethan L Magno

Title: Ethan L. Magno and Antibody-Drug Conjugate Innovation.

Introduction

Ethan L. Magno is an inventor associated with Cambridge, Massachusetts, and Harvard College. His patent work concerns stabilized trioxacarcin antibody-drug conjugates and their potential preparation and therapeutic use.

Latest Patents

The patent “Stabilized Trioxacarcin Antibody Drug Conjugates and Uses Thereof” describes antibody-drug conjugates in which a molecular payload is linked to an antibody or antibody fragment through linking and conjugating groups. It also covers methods for preparing the conjugates, pharmaceutical compositions, and methods of use and treatment. The disclosure further addresses precursor compounds, including trioxacarcins that are not conjugated to an antibody, and their compositions and uses. Magno is associated with 1 patent.

Career Highlights

Magno’s listed affiliation is Harvard College. The available information identifies his patent contribution but does not provide further details about his role, career history, or research activities.

Collaborations

The patent concerns antibody-drug conjugates, a field that brings together expertise in molecular payloads, chemical linking, antibody conjugation, and therapeutic development. The available information does not identify specific collaborators.

Conclusion

Ethan L. Magno’s identified patent focuses on stabilized trioxacarcin antibody-drug conjugates, their preparation, and their potential pharmaceutical and therapeutic applications.